Skip to content

The value of contrast-enhanced endoscopic ultrasound in the diagnosis of periampullary space-occupying lesions

The value of contrast-enhanced endoscopic ultrasound in the diagnosis of periampullary space-occupying lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092204
Enrollment
Unknown
Registered
2024-11-12
Start date
2024-11-15
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periampullary space-occupying lesions

Interventions

Gold Standard:The gold standard for final diagnosis was the pathologic diagnosis by puncture biopsy and the definitive histologic diagnosis by surgical resection of the specimen. For patients who did
Index test:contrast-enhanced endoscopic ultrasound

Sponsors

The Third People’s Hospital of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
38 Years to 89 Years

Inclusion criteria

Inclusion criteria: (a) age >18 years (b) malignant PSOL by surgery or pathologic biopsy, or benign PSOL confirmed by one year follow-up; (c) patients with preoperative CH-EUS and CT or MRI.

Exclusion criteria

Exclusion criteria: patients with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
The contrast intensity of CH-EUS for the diagnosis of PSOL;sensitivity;specificity;positive predictive value ;negative predictive value;accuracy ;

Countries

China

Contacts

Public ContactJing Shan

The Third People’s Hospital of Chengdu

tulip-sj@163.com+86 156 5885 0832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026